The Vitiligo market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Vitiligo: An Overview
The American Vitiligo Research foundation defines Vitiligo as a condition in which the skin loses melanin, the pigment that determines the color of skin, hair, and eyes. If the cells that do not produce melanin die or no longer produce melanin, slowing growing white patches of irregular shapes appear on the skin. The typical lesions on the skin can be defined as milky white, non-scaly macules that are present with distinct margins.
The evaluation of the patient with vitiligo entails a detailed history and a complete skin examination to assess disease severity and individual prognostic factors.
The treatments include phototherapy, topical and systemic immunosuppressants, and surgical techniques, which together may help in halting the disease, stabilizing depigmented lesions, and stimulating repigmentation. Choice of treatment depends on several factors including the subtype of the disease, the extent, distribution, and activity of disease as well as the patient’s age, phototype, effect on the quality of life, and motivation for treatment.
Vitiligo Market Key Facts
-
Vitiligo is a disease characterized by patches of skin depigmentation. Vitiligo’s global prevalence is 0.5%-2%, with reported rates varying geographically.
-
In a study by Kruger and Schallreuter 2020, more than 50 studies were found that used several methods and subgroups of the general population. The prevalence of vitiligo ranges from 0.06 to 2.28%, whereas this was 0.0–2.16% in children/adolescents populations.
-
According to the Vitiligo Research Foundation, the average prevalence of vitiligo is between 0.5% to 2% of the world population, but local numbers may vary from 0.004% to 9.98%, depending on the region and age group.
-
As per the estimates by DelveInsight, the Vitiligo prevalence is higher in females than males.
As per DelveInsight, Vitiligo Market Size is anticipated to increase during the study period owing to the development of targeted treatment and the launch of the therapies.
The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Vitiligo market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report gives a thorough detail of the Vitiligo market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Vitiligo Epidemiology
The epidemiology section covers insights about the historical and current Vitiligo patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Vitiligo Epidemiology Segmentation
-
Total prevalent cases of Vitiligo
-
Total diagnosed and treatable cases of Vitiligo
-
Gender-specific cases of Vitiligo
-
Age-specific cases of Vitiligo
-
Type-specific Diagnosed Prevalent cases of Vitiligo
Vitiligo Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Vitiligo market or expected to get launched in the market during the study period. The analysis covers Vitiligo market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Vitiligo Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.
Get the PDF Sample of the Report:- https://www.delveinsight.com/sample-request/vitiligo-market
Vitiligo Therapeutics Analysis
The Vitiligo market size is expected to grow during the forecast period owing to the increase in the prevalent cases, the better understanding of the disease, and the launch of the emerging treatments.
Key Companies in the Vitiligo Market include
-
Amgen
-
Pfizer
-
Arcutis Biotherapeutics
-
Incyte Corporation
-
Sun Pharma Global FZE
And others.
Vitiligo Therapies covered in the report include
-
Ruxolitinib
-
ARQ-252
-
AMG 714
-
AS012
-
PF-06651600
And many others.
Get More Detailed Insights into the Emerging Therapies & Key Companies:- https://www.delveinsight.com/sample-request/vitiligo-market
Table of Content
1. Key Insights
2. Executive Summary
3. Vitiligo Competitive Intelligence Analysis
4. Vitiligo Market Overview at a Glance
5. Vitiligo Disease Background and Overview
6. Vitiligo Patient Journey
7. Vitiligo Epidemiology and Patient Population
8. Vitiligo Treatment Algorithm, Current Treatment, and Medical Practices
9. Vitiligo Unmet Needs
10. Key Endpoints of Vitiligo Treatment
11. Vitiligo Marketed Products
12. Vitiligo Emerging Therapies
13. Vitiligo Seven Major Market Analysis
14. Attribute Analysis
15. Vitiligo Market Outlook (7 major markets)
16. Vitiligo Access and Reimbursement Overview
17. KOL Views on the Vitiligo Market.
18. Vitiligo Market Drivers
19. Vitiligo Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Request Sample Report here:- https://www.delveinsight.com/sample-request/vitiligo-market
Other Trending Healthcare Reports By DelveInsight
Bevacizumab Biosimilars Insight
DelveInsight’s, “Bevacizumab Biosimilar Insight” report provides comprehensive insights about 40+ companies and 40+ marketed and pipeline drugs in the Bevacizumab Biosimilars landscape. The report also covers the marketed and pipeline drug profiles, including clinical and non-clinical stage products.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/